Skip to content
2000
Volume 10, Issue 5
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

In 1991, Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) was introduced to assess the expression of Tyrosinase in the peripheral blood of melanoma patients, in order to identify the presence of Circulating Melanoma Cells. To date, hundreds of studies, some of which are reviewed here, were performed to assess the clinical value of tyrosinase expression alone, and/or, in addition to other molecular markers. Unfortunately no consensus on the utility of tyrosinase detection exists. In this paper, we underline the presence of too many variables that may interfere with the detection of circulating melanoma cells: from withdrawal and RNA extraction, to Reverse Transcriptase-Polymerase Chain Reaction and the assays used for the analysis of amplification products.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/156800910791517136
2010-08-01
2025-05-11
Loading full text...

Full text loading...

/content/journals/ccdt/10.2174/156800910791517136
Loading

  • Article Type:
    Research Article
Keyword(s): melanoma; peripheral blood; RT-PCR; Tyrosinase
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test